A DNA-based nano-immunoassay for the label-free detection of glial fibrillary acidic protein in multicell lysates-Reference-Cited by-同舟云学术

A DNA-based nano-immunoassay for the label-free detection of glial fibrillary acidic protein in multicell lysates

Published:2015-02 Issue:2 Volume:11 Page:293-300
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Ganau Mario,Bosco Alessandro,Palma Anita,Corvaglia Stefania,Parisse Pietro,Fruk Ljiljana,Beltrami Antonio Paolo,Cesselli Daniela,Casalis Loredana,Scoles Giacinto

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference38 articles.

1. Toward personalized cancer nanomedicine—past, present, and future;Stegh;Integr Biol,2013

2. Nanotechnology and cancer;Heath;Annu Rev Med,2008

3. Circulating endothelial progenitor cells in malignant gliomas;Rafat;J Neurosurg,2010

4. Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies;Ahmed;Expert Rev Neurother,2013

5. Proteomics, nanotechnology and molecular diagnostics;Johnson;Proteomics,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evaluation of Clinical Applications for the Detection of the Alzheimer’s Disease Biomarker GFAP;Critical Reviews in Analytical Chemistry;2024-08-23

2. Sirtuin 5 (SIRT5) Suppresses Tumor Growth by Regulating Mitochondrial Metabolism and Synaptic Remodeling in Gliomas;International Journal of Molecular Sciences;2024-08-22

3. Second Cancer Affecting the Central Nervous System: Systematic Literature Review Exploring the Link Between Malignant Melanoma and Glioblastoma;World Neurosurgery;2023-11

4. Latest Insights on Genomic and Epigenomic Mechanisms of Nanotoxicity;Impact of Engineered Nanomaterials in Genomics and Epigenomics;2023-05-15

5. Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease;Journal of Personalized Medicine;2022-06-10